Nyxoah S.A. (NASDAQ:NYXH) Short Interest Down 36.4% in March

Nyxoah S.A. (NASDAQ:NYXH) was the recipient of a significant drop in short interest in the month of March. As of March 15th, there was short interest totalling 63,700 shares, a drop of 36.4% from the February 28th total of 100,200 shares. Based on an average daily volume of 47,400 shares, the days-to-cover ratio is currently 1.3 days. Approximately 0.4% of the shares of the company are short sold.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the company. Kovack Advisors Inc. raised its position in shares of Nyxoah by 100.0% in the fourth quarter. Kovack Advisors Inc. now owns 20,000 shares of the company’s stock worth $160,000 after buying an additional 10,000 shares in the last quarter. LPL Financial LLC purchased a new stake in shares of Nyxoah in the 4th quarter valued at about $102,000. Geode Capital Management LLC boosted its position in shares of Nyxoah by 19.4% during the 4th quarter. Geode Capital Management LLC now owns 17,100 shares of the company’s stock valued at $137,000 after acquiring an additional 2,774 shares during the last quarter. Renaissance Technologies LLC purchased a new position in shares of Nyxoah during the fourth quarter worth about $187,000. Finally, Walleye Capital LLC increased its position in shares of Nyxoah by 23.9% in the fourth quarter. Walleye Capital LLC now owns 14,831 shares of the company’s stock worth $119,000 after purchasing an additional 2,862 shares during the last quarter.

Nyxoah Price Performance

NYXH stock traded down $0.67 during mid-day trading on Monday, reaching $6.98. 92,005 shares of the company traded hands, compared to its average volume of 46,856. The company has a fifty day moving average price of $10.35 and a 200-day moving average price of $9.36. Nyxoah has a 52-week low of $6.76 and a 52-week high of $13.50. The company has a market capitalization of $237.74 million, a P/E ratio of -3.73 and a beta of 1.42. The company has a debt-to-equity ratio of 0.21, a current ratio of 5.28 and a quick ratio of 4.95.

Nyxoah (NASDAQ:NYXH) last released its quarterly earnings data on Thursday, March 13th. The company reported ($0.49) EPS for the quarter, missing analysts’ consensus estimates of ($0.46) by ($0.03). The firm had revenue of $1.35 million during the quarter, compared to the consensus estimate of $2.02 million. Nyxoah had a negative net margin of 1,043.93% and a negative return on equity of 51.68%. As a group, analysts anticipate that Nyxoah will post -1.91 earnings per share for the current year.

Analyst Upgrades and Downgrades

NYXH has been the topic of several research reports. HC Wainwright lowered their price target on shares of Nyxoah from $17.00 to $15.00 and set a “buy” rating on the stock in a research report on Wednesday, March 26th. Stifel Nicolaus reduced their price objective on shares of Nyxoah from $16.00 to $15.00 and set a “buy” rating for the company in a research note on Friday, March 14th.

About Nyxoah

Nyxoah SA, a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. The company’s lead solution comprises Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea.